Julia Aulin
Researcher at Department of Medical Sciences; Cardiology
- E-mail:
- julia.aulin@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Download contact information for Julia Aulin at Department of Medical Sciences; Cardiology
Postdoctoral position at Department of Medical Sciences; Translational Neurology
- E-mail:
- julia.aulin@ucr.uu.se
- Visiting address:
- Akademiska Sjukhuset, Ing 85 3 tr
751 85 Uppsala - Postal address:
- Box 593
75124 UPPSALA
Researcher at UCR-Uppsala Clinical Research center
- E-mail:
- julia.aulin@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Julia Aulin at UCR-Uppsala Clinical Research center
Short presentation
MD, PhD.
Publications
Selection of publications
-
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
-
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Part of Journal of the American Heart Association, 2022
- DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
- Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
-
Biomarkers of inflammation in atrial fibrillation
2021
-
Part of Journal of Thrombosis and Haemostasis, p. 2287-2295, 2020
- DOI for Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
- Download full text (pdf) of Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
-
Part of Open heart, 2018
- DOI for Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
- Download full text (pdf) of Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
-
Part of Heart, p. 508-517, 2016
-
Part of American Heart Journal, p. 1151-1160, 2015
Recent publications
-
Part of Scientific Reports, 2026
- DOI for Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay
- Download full text (pdf) of Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay
-
Biomarkers for advancing diagnosis and prognosis in stroke
Part of Lancet Neurology, p. 406-420, 2026
- DOI for Biomarkers for advancing diagnosis and prognosis in stroke
- Download full text (pdf) of Biomarkers for advancing diagnosis and prognosis in stroke
-
Part of Open heart, 2025
- DOI for Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort study
- Download full text (pdf) of Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort study
-
Plasma profiles of neuroglial injury biomarkers after ischemic stroke
Part of Translational Stroke Research, p. 2185-2194, 2025
- DOI for Plasma profiles of neuroglial injury biomarkers after ischemic stroke
- Download full text (pdf) of Plasma profiles of neuroglial injury biomarkers after ischemic stroke
-
Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic Stroke
Part of Translational Stroke Research, 2025
All publications
Articles in journal
-
Part of Scientific Reports, 2026
- DOI for Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay
- Download full text (pdf) of Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay
-
Biomarkers for advancing diagnosis and prognosis in stroke
Part of Lancet Neurology, p. 406-420, 2026
- DOI for Biomarkers for advancing diagnosis and prognosis in stroke
- Download full text (pdf) of Biomarkers for advancing diagnosis and prognosis in stroke
-
Part of Open heart, 2025
- DOI for Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort study
- Download full text (pdf) of Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort study
-
Plasma profiles of neuroglial injury biomarkers after ischemic stroke
Part of Translational Stroke Research, p. 2185-2194, 2025
- DOI for Plasma profiles of neuroglial injury biomarkers after ischemic stroke
- Download full text (pdf) of Plasma profiles of neuroglial injury biomarkers after ischemic stroke
-
Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic Stroke
Part of Translational Stroke Research, 2025
-
Part of Journal of the American Heart Association, 2025
- DOI for Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
- Download full text (pdf) of Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
-
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
Part of Circulation, p. 1090-1100, 2024
-
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
-
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Part of Journal of the American Heart Association, 2022
- DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
- Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
-
Part of Journal of Thrombosis and Haemostasis, p. 2287-2295, 2020
- DOI for Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
- Download full text (pdf) of Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
-
Part of Open heart, 2018
- DOI for Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
- Download full text (pdf) of Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
-
Part of Heart, p. 508-517, 2016
-
Part of American Heart Journal, p. 1151-1160, 2015
-
Part of European Heart Journal, p. 1115-1116, 2014